You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Boehringer Ingelheim
McKesson
Harvard Business School
Moodys

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 8,070,607

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,070,607
Title:Competition game system and game apparatus
Abstract: A competition game system designed such that tactical data created based on respective results of input operations to manual operation sections of two game apparatuses are transmitted and received between the game apparatuses to allow a competition game having an identical event to be progressed in each of the game apparatuses based on the transmitted and received tactical data. Each of the game apparatuses comprises an action-setting section 305 adapted to create player-side tactical data corresponding to a content of an input operation from the manual operation section 10A, a communication control section 306 adapted to transmit the player-side tactical data created by the action-setting section 305, to the opponent\'s game apparatus, and receive opponent-side tactical data from the opponent\'s game apparatus, through a communication section 130, a determination section 307 adapted to determine a competition result, based on the player-side and opponent-side tactical data, and an image display control section 302 adapted to display a game image onto a display unit 3 according to the determined competition result. The competition game system of the present invention makes it possible to efficiently achieve a competition game while exchanging minimum data between a plurality of game apparatuses having the same configuration, without setting a master-servant relationship to the game apparatuses.
Inventor(s): Takahashi; Naoki (Kobe, JP), Uchiyama; Satoshi (Kobe, JP), Inoue; Yoshihisa (Kobe, JP), Kitakaze; Yusuke (Kobe, JP)
Assignee: Konami Digital Entertainment Co., Ltd. (Tokyo, JP)
Application Number:11/887,288
Patent Claims:see list of patent claims

Details for Patent 8,070,607

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Konami Digital Entertainment Co., Ltd. (Tokyo, JP) 2025-03-31 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Moodys
Medtronic
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.